Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025
Venus Concept (NASDAQ: VERO), a global medical aesthetic technology leader, has scheduled its third quarter fiscal year 2025 financial results release for November 13, 2025, before market opening.
The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring a management discussion and Q&A session. Participants can join via phone using access code 13756285 or watch the live webcast on the company's investor relations website. A two-week replay will be available for those unable to attend.
Venus Concept (NASDAQ: VERO), leader globale della tecnologia medica estetica, ha programmato la pubblicazione dei risultati finanziari del terzo trimestre dell'anno fiscale 2025 per 13 novembre 2025, prima dell'apertura del mercato.
L'azienda terrà una conference call alle 8:00 a.m. Eastern Time nello stesso giorno, con una discussione da parte del management e una sessione di Q&A. I partecipanti possono partecipare tramite telefono utilizzando il codice di accesso 13756285 o seguire la diretta webcast sul sito degli investitori dell'azienda. Una replica di due settimane sarà disponibile per chi non potrà partecipare.
Venus Concept (NASDAQ: VERO), líder global en tecnología estética médica, ha programado la publicación de sus resultados financieros del tercer trimestre del año fiscal 2025 para el 13 de noviembre de 2025, antes de la apertura del mercado.
La compañía celebrará una llamada de conferencias a las 8:00 a.m. hora del Este ese mismo día, con una discusión de la dirección y una sesión de preguntas y respuestas. Los participantes pueden unirse por teléfono usando el código de acceso 13756285 o ver la transmisión en vivo en el sitio web de relaciones con inversores de la empresa. Habrá una repetición de dos semanas para quienes no puedan asistir.
Venus Concept (NASDAQ: VERO), 글로벌 의료 미용 기술 분야의 선두주자, 2025 회계 연도 제3분기 재무 실적 발표를 2025년 11월 13일에 장 마감 전으로 예정했습니다.
회사는 같은 날 같은 시각에 동부 표준시 8:00에 컨퍼런스 콜을 개최하며 경영진의 논의와 질의응답이 진행됩니다. 참가자는 전화로 접근 코드 13756285를 사용하거나 회사의 투자자 관계 웹사이트에서 생방송 웹캐스트를 시청할 수 있습니다. 참석하지 못한 사람들을 위해 2주간의 재방송이 제공됩니다.
Venus Concept (NASDAQ: VERO), leader mondial des technologies esthétiques médicales, a prévu de publier ses résultats financiers du troisième trimestre de l'exercice 2025 le 13 novembre 2025, avant l'ouverture du marché.
La société organisera une conférence téléphonique à 8h00, heure de l'Est le même jour, avec une discussion de la direction et une session de questions-réponses. Les participants peuvent se joindre par téléphone en utilisant le code d'accès 13756285 ou regarder la diffusion en direct sur le site des relations investisseurs de l'entreprise. Une rediffusion de deux semaines sera disponible pour ceux qui ne peuvent pas assister.
Venus Concept (NASDAQ: VERO), weltweit führend in der medizinisch ästhetischen Technologie, hat die Veröffentlichung der Finanzergebnisse zum dritten Quartal des Geschäftsjahres 2025 auf 11. November 2025 festgelegt, vor Börseneröffnung.
Das Unternehmen wird am selben Tag eine Telefonkonferenz um 8:00 Uhr Eastern Time abhalten, mit einer Management-Diskussion und einem Q&A. Teilnehmer können sich telefonisch mit dem Zugangscode 13756285 einwählen oder den Live-Webcast auf der Investor-Relations-Website des Unternehmens ansehen. Eine zweiwöchige Wiederholung wird für diejenigen verfügbar sein, die nicht teilnehmen können.
فينوس كونسبت (NASDAQ: VERO)، رائدة عالميًا في تكنولوجيا التجميل الطبي، حددت موعد إصدار نتائجها المالية للربع الثالث من السنة المالية 2025 ليكون في 13 نوفمبر 2025، قبل افتتاح السوق.
ستعقد الشركة مكالمة مؤتمر في 8:00 صباحًا بتوقيت شرق الولايات المتحدة في اليوم نفسه، مع مناقشة من الإدارة وجلسة أسئلة وأجوبة. يمكن للمشاركين الانضمام عبر الهاتف باستخدام رمز الدخول 13756285 أو مشاهدة البث المباشر على موقع علاقات المستثمرين بالشركة. سيكون هناك إعادة بث لمدة أسبوعين لأولئك الذين لا يستطيعون الحضور.
Venus Concept (NASDAQ: VERO),全球医疗美学科技的领导者,已将其 2025 财年第三季度财务业绩公布日期安排在 2025 年 11 月 13 日,在市场开盘前。
公司将于同日早上 美东时间 8:00 举行电话会议,包含管理层讨论与问答环节。参与者可通过电话使用访问码 13756285 参与,或在公司的投资者关系网站观看现场网络直播。若无法出席,将提供两周的重播。
- None.
- None.
TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, November 13, 2025.
Management will host a conference call at 8:00 a.m. Eastern Time on November 13, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to participate may dial 877-407-2991 (+1 201-389-0925 for international callers) and provide access code 13756285. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13756285. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.

Investor Relations Contact: ICR Healthcare on behalf of Venus Concept Mike Piccinino, CFA VenusConceptIR@ICRHealthcare.com